Novus Therapeutics
NVUS
#10269
Rank
A$30.43 M
Marketcap
A$21.19
Share price
-5.19%
Change (1 day)
N/A
Change (1 year)

Earnings for Novus Therapeutics (NVUS)

Earnings in 2020 (TTM): -A$17.9 Million

According to Novus Therapeutics 's latest financial reports the company's current earnings are N/A. In 2019 the company made an earning of -A$20.59 Million a decrease over its 2018 earnings that were of -A$20.41 Million.

Earnings history for Novus Therapeutics from 2014 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-A$17.9 Million-13.04%
2019-A$20.59 Million0.88%
2018-A$20.41 Million-10.03%
2017-A$22.68 Million-59.01%
2016-A$55.33 Million-15.77%
2015-A$65.68 Million92.91%
2014-A$34.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Omeros Corporation
OMER
-A$0.18 Billion 885.91%๐Ÿ‡บ๐Ÿ‡ธ USA